Literature DB >> 25611773

Sentinel lymph node biopsy in breast cancer: a work in progress.

Abhishek Chatterjee1, Nicholas Serniak, Brian J Czerniecki.   

Abstract

The sentinel lymph node biopsy is a safe, accurate operation for the initial staging of breast cancer. Over the last decade, there has been increasing literature supporting its use, and it is now considered a standard of care for the initial evaluation of metastatic spread to the axillary lymph node chain.

Entities:  

Mesh：

Year:  2015        PMID： 25611773      PMCID： PMC4304410          DOI： 10.1097/PPO.0000000000000090

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


  45 in total

1.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

2.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

3.  Active macromolecule uptake by lymph node antigen-presenting cells: a novel mechanism in determining sentinel lymph node status.

Authors:  M B Faries; I Bedrosian; C Reynolds; H Q Nguyen; A Alavi; B J Czerniecki
Journal:  Ann Surg Oncol       Date:  2000-03       Impact factor: 5.344

4.  Predictors and outcomes of completion axillary node dissection among older breast cancer patients.

Authors:  Sara H Javid; Hao He; Larissa A Korde; David R Flum; Benjamin O Anderson
Journal:  Ann Surg Oncol       Date:  2014-03-01       Impact factor: 5.344

5.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Authors:  Viviana Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra; Oreste Gentilini; Mauro G Mastropasqua; Giovanni Mazzarol; Samuele Massarut; Jean-Rémi Garbay; Janez Zgajnar; Hanne Galatius; Angelo Recalcati; David Littlejohn; Monika Bamert; Marco Colleoni; Karen N Price; Meredith M Regan; Aron Goldhirsch; Alan S Coates; Richard D Gelber; Umberto Veronesi
Journal:  Lancet Oncol       Date:  2013-03-11       Impact factor: 41.316

6.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Authors:  Judy C Boughey; Vera J Suman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Henry M Kuerer; Monet Bowling; Teresa S Flippo-Morton; David R Byrd; David W Ollila; Thomas B Julian; Sarah A McLaughlin; Linda McCall; W Fraser Symmans; Huong T Le-Petross; Bruce G Haffty; Thomas A Buchholz; Heidi Nelson; Kelly K Hunt
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

7.  Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Authors:  Erika A Newman; Michael S Sabel; Alexis V Nees; Anne Schott; Kathleen M Diehl; Vincent M Cimmino; Alfred E Chang; Celina Kleer; Daniel F Hayes; Lisa A Newman
Journal:  Ann Surg Oncol       Date:  2007-05-19       Impact factor: 5.344

8.  Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.

Authors:  Yosuke Tanaka; Hironori Maeda; Yasuhiro Ogawa; Akihito Nishioka; Satoshi Itoh; Kei Kubota; Hironobu Ue; Kimiko Nakatani; Shiro Sasaguri
Journal:  Oncol Rep       Date:  2006-04       Impact factor: 3.906

9.  Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Gary H Lyman; Sarah Temin; Stephen B Edge; Lisa A Newman; Roderick R Turner; Donald L Weaver; Al B Benson; Linda D Bosserman; Harold J Burstein; Hiram Cody; James Hayman; Cheryl L Perkins; Donald A Podoloff; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

Review 10.  Contraindications of sentinel lymph node biopsy: are there any really?

Authors:  George M Filippakis; George Zografos
Journal:  World J Surg Oncol       Date:  2007-01-29       Impact factor: 2.754
View more
  10 in total

Review 1.  The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review.

Authors:  Juan C Vázquez; Antonio Piñero; Francisco J de Castro; Ana Lluch; Miguel Martín; Agustí Barnadas; Emilio Alba; Álvaro Rodríguez-Lescure; Federico Rojo; Julia Giménez; Ivan Solá; Maria J Quintana; Xavier Bonfill; Gerard Urrutia; Pedro Sánchez-Rovira
Journal:  Clin Transl Oncol       Date:  2022-09-25       Impact factor: 3.340

Review 2.  Review of methods for intraoperative margin detection for breast conserving surgery.

Authors:  Benjamin W Maloney; David M McClatchy; Brian W Pogue; Keith D Paulsen; Wendy A Wells; Richard J Barth
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

3.  Establishment of a model for predicting sentinel lymph node metastasis in early breast cancer based on contrast-enhanced ultrasound and clinicopathological features.

Authors:  Lina Wang; Juntao Li; Jianghua Qiao; Xiaoxia Guo; Xiaolin Bian; Lanwei Guo; Zhenzhen Liu; Zhenduo Lu
Journal:  Gland Surg       Date:  2021-05

4.  Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?

Authors:  Steven J Katz; Sarah T Hawley; Irina Bondarenko; Reshma Jagsi; Kevin C Ward; Timothy P Hofer; Allison W Kurian
Journal:  Breast Cancer Res Treat       Date:  2017-07-08       Impact factor: 4.624

5.  Clinical translation of handheld optical coherence tomography: practical considerations and recent advancements.

Authors:  Guillermo L Monroy; Jungeun Won; Darold R Spillman; Roshan Dsouza; Stephen A Boppart
Journal:  J Biomed Opt       Date:  2017-12       Impact factor: 3.170

6.  Neoplasm of uncertain behaviour of the breast-a retrospective study in a breast unit.

Authors:  Xavier de Sousa; Pedro Santos Ferreira; Luís Branco; Jorge Simões; Matilde Gonçalves; Manuel Vítor Rigueira; Luís Cortez
Journal:  Ecancermedicalscience       Date:  2018-05-31

7.  Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.

Authors:  Anne Cowppli-Bony; Brigitte Trétarre; Emilie Marrer; Gautier Defossez; Laetitia Daubisse-Marliac; Gaelle Coureau; Pamela Minicozzi; Anne-Sophie Woronoff; Patricia Delafosse; Florence Molinié
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

8.  Role of Hormonal Receptor in Predicting Sentinel Lymph Node Metastasis in Early Breast Cancer.

Authors:  Dedy Hermansyah; Wahyu Indra; Desiree A Paramita; Edwin Saleh Siregar
Journal:  Med Arch       Date:  2022-02

9.  Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes.

Authors:  Leeya F Pinder; Ronda Henry-Tillman; David Linyama; Victor Kusweje; Jean-Baptiste Nzayisenga; Aaron Shibemba; Vikrant Sahasrabuddhe; Kennedy Lishimpi; Mulindi Mwanahamuntu; Michael Hicks; Groesbeck P Parham
Journal:  J Glob Oncol       Date:  2017-09-08

10.  Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer.

Authors:  Meijie Liu; Ning Mao; Heng Ma; Jianjun Dong; Kun Zhang; Kaili Che; Shaofeng Duan; Xuexi Zhang; Yinghong Shi; Haizhu Xie
Journal:  Cancer Imaging       Date:  2020-09-15       Impact factor: 3.909
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.